Cannabis
Hanway Associates Completes Sale of HAPP Holdings Events Portfolio, Including Cannabis Europa, to Global Media and Data Group NOBL
London-based Hanway Associates, the leading cannabis industry strategic consultancy, has successfully sold HAPP Holdings Limited to global player NOBL Group, handing over the reins to the group’s portfolio including the massively-successful conference series, Cannabis Europa.
Cannabis Europa, was co-founded in 2018 as a joint venture between Hanway Associates and NOBL Group portfolio company, Prohibition Partners, and saw over 3,000 delegates attend 3 European events, fast-became the definitive, market leading annual conference for the cannabis industry.
HAPP Holdings went on to launch the inaugural European Cannabis Week in 2019. Co-Founder Alastair Moore will remain on as Creative Director, with Rachel Jones joining as Managing Director of HAPP Holdings. Prior to Cannabis Europa, Rachel held senior leadership positions at The FT Live, the global event arm of The Financial Times.
Hanway Associates, which advises a wide range of businesses, institutions, investors and high-net-worth-individuals, is eyeing growth in the UK and abroad, with a range of new propositions and partnerships planned for 2020.
Alastair Moore said: “In only two years, the Hanway Associates team built a platform that has had a huge impact on the industry and has created a well-respected forum for discussion, debate and opportunity-sharing around the burgeoning cannabis industry.
“I’m incredibly proud of Cannabis Europa and European Cannabis Week, but now felt like the right time for us to hand over the reins fully. The team at NOBL, who have been invaluable long-term partners, are perfectly positioned for rapid global expansion of the HAPP Holdings platform.
“This deal is a proof of concept for us at Hanway, showing that we can build, operate and sell companies that connect people, engage professional audiences and bring the cannabis industry into the mainstream” added Moore.
Stephen Murphy, Founder and CEO of The NOBL Group said: “We have worked with Alastair and Hanway Associates for a long time and they have worked tirelessly to help make Cannabis Europa what it is today.
“We are are thrilled to bring this brilliant platform within the ecosystem of a global group which will be crucial in helping us achieve our ambitious expansion plans. We will be taking this established, must-attend cannabis conference series to numerous new markets, supercharging our mission to open up, demystify and facilitate access to this exciting industry.”
SOURCE Hanway Associates
Cannabis
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Innocan2 weeks ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf2 weeks ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis2 weeks ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
Cannabis5 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
SCHWAZZE6 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis5 days ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Humboldt5 days ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
-
Cannabis3 days ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III